158 related articles for article (PubMed ID: 27344000)
1. A systematic review comparing sex differences in cognitive function in schizophrenia and in rodent models for schizophrenia, implications for improved therapeutic strategies.
Leger M; Neill JC
Neurosci Biobehav Rev; 2016 Sep; 68():979-1000. PubMed ID: 27344000
[TBL] [Abstract][Full Text] [Related]
2. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
3. Gender differences measured by the MATRICS consensus cognitive battery in chronic schizophrenia patients.
Zhang B; Han M; Tan S; De Yang F; Tan Y; Jiang S; Zhang X; Huang XF
Sci Rep; 2017 Sep; 7(1):11821. PubMed ID: 28928440
[TBL] [Abstract][Full Text] [Related]
4. Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically.
Brown JW; Rueter LE; Zhang M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():53-62. PubMed ID: 24269664
[TBL] [Abstract][Full Text] [Related]
5. Neurocognition, psychopathology, and subjective disturbances in schizophrenia: a comparison between short-term and remitted patients.
Comparelli A; De Carolis A; Corigliano V; Romano S; Kotzalidis G; Brugnoli R; Tamorri S; Curto M; Tatarelli R; Ferracuti S; Girardi P
Compr Psychiatry; 2012 Oct; 53(7):931-9. PubMed ID: 22444951
[TBL] [Abstract][Full Text] [Related]
6. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
Huguelet P; Nicastro R; Zanello A
Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
[TBL] [Abstract][Full Text] [Related]
7. Assessment of cognitive functions in animal models of schizophrenia.
Nikiforuk A
Pharmacol Rep; 2018 Aug; 70(4):639-649. PubMed ID: 29894866
[TBL] [Abstract][Full Text] [Related]
8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
9. [Measuring the cognitive deficit associated with schizophrenia: presentation of the MATRICS neuropsychological test battery].
Sarolta K; Pál C; István B
Neuropsychopharmacol Hung; 2007 Oct; 9(3):143-50. PubMed ID: 18399033
[TBL] [Abstract][Full Text] [Related]
10. Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.
Young JW; Powell SB; Risbrough V; Marston HM; Geyer MA
Pharmacol Ther; 2009 May; 122(2):150-202. PubMed ID: 19269307
[TBL] [Abstract][Full Text] [Related]
11. The MCCB impairment profile in a Spanish sample of patients with schizophrenia: Effects of diagnosis, age, and gender on cognitive functioning.
Rodriguez-Jimenez R; Dompablo M; Bagney A; Santabárbara J; Aparicio AI; Torio I; Moreno-Ortega M; Lopez-Anton R; Lobo A; Kern RS; Green MF; Jimenez-Arriero MA; Santos JL; Nuechterlein KH; Palomo T
Schizophr Res; 2015 Dec; 169(1-3):116-120. PubMed ID: 26416441
[TBL] [Abstract][Full Text] [Related]
12. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
Kake TR; Garrett N; Te Aonui M
Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
[TBL] [Abstract][Full Text] [Related]
13. Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.
Neill JC; Barnes S; Cook S; Grayson B; Idris NF; McLean SL; Snigdha S; Rajagopal L; Harte MK
Pharmacol Ther; 2010 Dec; 128(3):419-32. PubMed ID: 20705091
[TBL] [Abstract][Full Text] [Related]
14. Cognitive improvement in first-episode schizophrenia and healthy controls: A 6-year multi-assessment follow-up study.
Fu S; Czajkowski N; Torgalsbøen AK
Psychiatry Res; 2018 Sep; 267():319-326. PubMed ID: 29957548
[TBL] [Abstract][Full Text] [Related]
15. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.
Green MF
J Clin Psychiatry; 2006; 67 Suppl 9():3-8; discussion 36-42. PubMed ID: 16965182
[TBL] [Abstract][Full Text] [Related]
16. Cognitive deficit awareness in schizophrenia: absent, intact, or somewhere in-between?
Balzan RP; Neaves A; Denson LA; Liu D; Galletly C
Cogn Neuropsychiatry; 2014; 19(6):471-84. PubMed ID: 24749790
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.
Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ
J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774
[TBL] [Abstract][Full Text] [Related]
18. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB).
McCleery A; Green MF; Hellemann GS; Baade LE; Gold JM; Keefe RS; Kern RS; Mesholam-Gately RI; Seidman LJ; Subotnik KL; Ventura J; Nuechterlein KH
Psychol Med; 2015; 45(12):2657-66. PubMed ID: 25916421
[TBL] [Abstract][Full Text] [Related]
19. [Cognitive deficit in schizophrenia: MATRICS Consensus Cognitive Battery].
Rodríguez-Jiménez R; Bagney A; Moreno-Ortega M; García-Navarro C; Aparicio AI; López-Antón R; de la Oliva J; Jiménez-Arriero MÁ; Santos JL; Lobo A; Palomo T
Rev Neurol; 2012 Nov; 55(9):549-55. PubMed ID: 23111994
[TBL] [Abstract][Full Text] [Related]
20. [MATRICS consensus cognitive battery--standard for the assessment of cognitive functions in clinical trials in schizophrenia].
Jedrasik-Styła M; Ciołkiewicz A; Denisiuk M; Linke M; Parnowska D; Gruszka A; Jarema M; Wichniak A
Psychiatr Pol; 2012; 46(2):261-71. PubMed ID: 23214396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
